Learn
Looking for more information?
Contact our responsive and friendly client services team any time.
Current price
$15.12
▾0.15 (1.00%)
Last trade: 12/09, 9:51AM
Market cap
$757.18m
Market closed
Talk to Clinuvel Pharmaceuticals Limited directly.
Sign up to their Investor Hub for direct access to the Clinuvel Pharmaceuticals Limited team, ask them questions, and see personal updates.
Investor Presentations
Principal Activity
Clinuvel Pharmaceuticals Limited (CUV) is a biopharmaceutical company focused on developing drugs for the treatment of a range of severe skin disorders. CUV's lead compound is SCENESSE (afamelanotide), a drug targeting erythropoietic protoporphyria (EPP). Former Names EpiTan Limited (EPT),28/02/2006
Address
Level 5/160 Queen St, Melbourne VIC 3000, Australia
Website
News
Announcements
Filter
| Announcement | T+2 Movement | Date |
|---|---|---|
Market Data
Day
3m
1yr
5yr
Current price
$15.12
Open price
-
Day low-high
-
Price change
Percent change
Previous close
-
Volume
-
Turnover
-
Bid price
-
Ask price
-
Market cap
-
Shares outstanding
-
Year high
-
Year low
-
Year low-high
-
Earnings per share
-
Price/earnings ratio
-
Dividend yield
-
Dividend per share
-
Franking
-
Investor Presentations
News
Sector Peers
| Company | Market Cap | ||
|---|---|---|---|
Copyright © 2024 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.
Support
Live Chat
Markets
Copyright © 2024 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.